EHMSG 2020 Virtual Conference | Live Sessions
PROGRAMME
SATURDAY, SEPTEMBER 18, 2021
All times are Central European Summer Time (CEST)
08.00 – 08.15 Session 1 - Welcome and introduction
Mirjana Rajilic Stojanovic & Tomica Milosavljevic (Belgrade, Serbia)
08.15 – 08.35 Session 2 - Introductory lecture
A tribute to Samy Cadranel: H. pylori infection in Pediatrics beginning in Brussels
Patrick Bontems (Brussels, Belgium)
08.35 - 09.35 Session 3 - Gastric carcinogenesis symposium
08.35 – 08.55
Quiescent stem cells: differentiated cells reprogram to fuel repair, metaplasia and neoplasia in the adult stomach
Jason C Mills (St Louis, MI, USA)
08.55 – 09.15
The hippo pathway in gastric carcinogenesis
Christine Varon (Bordeaux, France)
09.15 – 09.35
Extracellular vesicles from cancer-associated fibroblasts induce drug resistance
Takatsugu Ishimoto (Kumamoto, Japan)
09.35 - 09.45 Coffee Break
09.45 - 11.05 Session 4 - Gastric cancer symposium
09.45 – 10.05
Autoimmune gastritis and risk of GC
Christian Abnet (Rockville, MD, USA)
10.05 – 10.25
How to follow patients with gastric premalignant lesions
Tamara Matysiak Budnik (Nantes, France)
10.25 – 10.45
Mistakes in GC screening
Marcis Leja (Riga, Latvia)
10.45 – 11.05
Elimination of GC related deaths in Japan
Mototsugu Kato (Hakadate, Japan)
11.05 - 12.05 Session 5 - RICHEN Symposium
12.05 – 13.00 Lunch Break
13.00 - 13.15 Session 6 - Awarding of the Marshall & Warren Medal
Dulciene Queiroz (Belo Horizonte, Brazil)
13.15 – 14.35 Session 7 - H. pylori treatment symposium
13.15 – 13.35
Pathways of antimicrobial resistance through data sciences
Niyaz Ahmed (Hyderabad, India)
13.35 – 13.55
The Korean registry on H. pylori eradication (Koreg): Transition in therapy
Joo Sung Kim (Seoul, Korea)
13.55 – 14.15
What we have learned from the European H. pylori registry (HpEuReg)
Javier Gisbert (Madrid, Spain)
14.15 – 14.35
Role of meta-analysis of H. pylori in the era of antimicrobial stewardship
David Graham (Houston, TX, USA)
14.35 – 14.45 5 Min Break
14.45 – 16.25 Session 8 - Microbiota Symposium
14.45 – 15.05
Gastric microbiota changes during gastric carcinogenesis as a diagnostic biomarker
Jae Yong Park (Seoul, Korea)
15.05 – 15.25
Correlation of microbiota composition and COVID immunity
Mirjana Rajilic Stojanovic (Belgrade, Serbia)
15.25 – 15.45
Million microbiome from humans project, MMHP
Lars Engstrand (Stockholm, Sweden)
15.45 – 16.05
How gut microbiota alters the brain
Gerard Clarke (Cork, Ireland)
16.05 – 16.25
Microbiota in NAFLD/MAFLD
Herbert Tilg (Innsbruck, Austria)
16.25 – 16.40 Coffee Break
16.40 – 18.00 Session 9 - FMT symposium
16.40 – 17.00
FMT in the COVID era
Josbert Keller (The Hague, The Netherlands)
17.00 – 17.20
COVID risk during endoscopy and FMT
Gianluca Ianiro (Rome, Italy)
17.20 – 17.40
FMT for IBD
Sam Costello (Adelaide, Australia)
17.40 – 18.00
FMT to newborns
Katri Korpela (Helsinki, Finland)
18.00 – 18.30 Session 10 - Debate: Tools for modulating gut microbiota function, probiotics vs. prebiotics
18.00 – 18.15
• Benefit of Prebiotics
Petia Petkova Datchary, Würzburg, Germany
18.15 – 18.30
• Benefit of Probiotics
Muriel Derrien, Palaiseau, France
18.30 – 19.00 Session 11 - Closing Session
18.30 – 18.40
Poster Awards
18.40 – 19.00
Presentation of the Workshop 2022 in Glasgow, United Kingdom
Georgina Hold (Sydney, Australia)